Amisulpride (or SOLIAN®) is mainly prescribed to treat schizophrenia and dysthymia.
Class: Atypical (AAP)
FDA Approval: International Only (Asia, Europe, Australia, South Africa, Brazil)
Dosage Forms: 50 mg, 100 mg, 200 mg, 400 mg
Biological Half-life: 12 hours
Side Effects: Dizziness, headache, anxiety, insomnia, nausea, hypersalivation, hyperactivity, movement problems
Routes of Administration: Oral, IV
Pregnancy Category: C (AU)